Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancer

15 Mar 2023

Abstract excerpt

Recently, immune checkpoint inhibitors (ICIs), such as programmed cell death 1 (PD-1) monoclonal antibodies (mAbs), have revolutionized the treatment of malignant tumors. Therefore, the number of studies aiming to screen and identify new immune checkpoint molecules for antitumor immunotherapy is increasing. Signaling lymphocytic activation molecule (SLAM) family members are mainly expressed by and regulate the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Immune Cell Function and Interaction

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36931016
DOI: 10.1016/j.tranon.2023.101654

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancerPMID 36931016Read ↗

SLAMF8, a potential novel immune checkpoint molecule, is associated with the prognosis of colorectal cancerSemantic proximity Read ↗

The prognostic and immune significance of SLAMF9 in pan-cancer and validation of its role in colorectal cancerSemantic proximity Read ↗

SLAMF6 appears bidirectional in immune regulation of different cancersSemantic proximity Read ↗

SLAMF7 predicts prognosis and correlates with immune infiltration in serous ovarian carcinomaSemantic proximity Read ↗

The Expression Patterns of Immune Checkpoint Molecules in Colorectal Cancer: An Analysis Based on Microsatellite StatusSemantic proximity Read ↗

Expression Patterns of Immune Checkpoint Molecules in Colorectal Cancer: An Analysis Based on Microsatellite StatusSemantic proximity Read ↗

PD-L1 Expression in High-Risk Early-Stage Colorectal Cancer—Its Clinical and Biological Significance in Immune MicroenvironmentSemantic proximity Read ↗

LIMK1: A Promising Prognostic and Immune Infiltration Indicator in Colorectal CancerSemantic proximity Read ↗

SLAMF8 expression predicts the efficacy of anti‐PD1 immunotherapy in gastrointestinal cancersSemantic proximity Read ↗

Role of SOCS1 in tumor progression and therapeutic applicationSemantic proximity Read ↗

Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer TypesSemantic proximity Read ↗

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.